Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2

Development

Volumn 124, Issue 17, 1997, Pages 3375-3384

  Iseki, S ^a,b   Wilkie, A O M ^c   Heath, J K ^d   Ishimaru, T ^a,b   Eto, K ^b   Morriss Kay, G M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cell proliferation; FGF2; FGFR2; Human; Mouse fetus; Osteogenesis; Skull

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; MESSENGER RNA; OSTEOPONTIN;

ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIATION; FETUS; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKULL DEVELOPMENT; TISSUE DISTRIBUTION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CRANIAL SUTURES; CRANIOSYNOSTOSES; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; MUTATION; OSTEOGENESIS; OSTEOPONTIN; PREGNANCY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIALOGLYCOPROTEINS; SIGNAL TRANSDUCTION; SKULL;

ANIMALIA;

EID: 0030833319     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Alvarez-Bolado, G., Rosenfeld, M. G. and Swanson, L. W. (1995). Model of forebrain regionalisation based on spatio-temporal patterns of POU-III homeobox gene expression, birthdutes, and morphological features. J. Camp. Neurol. 355, 237-295.
2. Bellus, G. A., Gaudenz, K., Zackai, E. H., Clarke, L. A., Szabo, J., Krancomano, C. A. and Muenke, M. (1996). Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genetics 14, 174-176.
3. Bresnick, S. and Sehendel, S. (1995). Crouzon's disease correlates with low fibroblastic growth factor receptor activity in stenosed cranial sutures. J. Craniofac. Surg. 6, 245-248.
4. Cinalli, G., Renler, D., Sebag, G., Saints-Rose, C., Arnaud, K. and Pierre- Kahn, A. (1995). Cronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture. J Neumsurg. 83, 575-582.
5. Colvin, J. S., Bohne, B. A., Harding, G. W., McEwen, D. G. and Ornitz, D. M. (1996). Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12, 390-397.
6. Deng, C., Wynshaw-Boris, A., Shen, M., Daugherty, C., Ornltz, D. M. and Leder, P. (1994). Murine FGFR-1 is required for early postimplantation growth and axial organisation. Genes Dev. 8, 3045-3058.
7. Deng, C., Wynshaw-Boris, A., Zhou K., Kuo, A. and Leder P. (1996), Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.
8. El Ghouzzi, V. E., Le Merrer, M. L., Perrin-Schmltt, F., Lajeunie, E., Benit, P., Renier, D., Bourgeois, P., Bolcato-Bellemin, A-L., Munnich, A. and Bonaventure, J. (1997). Mutations of the TWIST gene in the Sacthre-Chotzen syndrome. Nature Genet. 15, 4 2-46.
9. Fedarko, N. S., Vetter, U. K., Weinstein, S. and Robey, P. G. (1992). Age-related changes in hyaluronan, proteoglycan, collagen and osteoncctin synthesis by human bone cells. J. Cell Physiol. 151, 215-227.
10. Flaumenhaft, R., Moscatelli, D., Sakscla, O. and Rifkin, D. B. (1989). Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator and DNA synthesis. J. Cell Physiol. 140, 75-81.
11. Flaumenhaft, R., Moscatelli, D. and Rifkin, D.B. (1990). Heparin and heparan sulphate increase the radius of diffusion and action of basic ribroblast growth factor. J. Cell Rial. 111, 1651-1659.
12. Folkman, J., Klagsbrun, M., Sasse, J., Wadzlnski, M., Ingber, D. and Vlodavsky, I. (1988). A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am. J. Pathol. 130, 393-400.
13. Galvin, B. D., Hart, K. C., Meyer, A. N. and Webster, M. K. (1996). Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimaeras. P roc. Nalt. Acad. Sci. USA 93, 7894-9.
14. Howard, T. D., Paznekas, W. A., Green, E. D., Chiang, L. C., Ma, N., Ortiz De Luna, R. I., Delgado, C. G., Gonzalez-Ramos, M., Kline, A. D. and Jabs, K. W. (1997). Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nature Genet. 15, 36-41.
15. Johnson, D. K. and Williams, L. T. (1993). Structural and functional diversity in the FGF receptor multigene family, Adv. Cancer. Res. 60, 1-41.
16. Mason, I. J. (1994). The ins and outs of fibroblast growth factors. Cell 78, 547-552.
17. Miki, T., Rottaro, D. P., Fleming, T. P., Smith, C. L., Burgess, W. H., Chan, A-M. L. and Aaronson, S. A. (1992). Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. USA 89, 246-250.
18. Moloney, D. M., Wall, S. A., Ashworth, G. J., Oldridge, M., Glass, I. A., Francomano, C. A., Menke, M. and Wilkle, A. O. M. (1997). Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet 349, 1059-1062.
19. Moscatelli, D. (1994). Autocrine downregulation of fibroblast growth factor receptors in F9 tcratocarvinoma cells. J. Cell Physiol. 160, 555-62.
20. Muenke, M., Schell, U., Hehr, A., Robin, N. H., I.osken, H. W., Schinzel, A., Pulleyn, L. J., Rutland, P., Reardon, W., Malcolm, S. and Winter, R. M. (1994). A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nature Genet. 8, 269-274.
21. Muenke, M. and Schell, U. (1995). Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11, 308-313.
22. Muneoka, K., Wanek, N., Trevino, C. and Bryant, S. V. (1990). Exo utero surgery. In Postimplantation Mammalian Embryos: A practical Approach fed. A. J. Copp and D. L. Cockroft), pp41-59. IRL Press at Oxford University Press, Oxford.
23. Naski, M. C., Wang, Q., Xu, J. and Ornitz, D. M. (1996). Graded activation of fibroblast growth factor receptor 3 by mutations causing achundroplasia and thanatophoric dysplasia. Nature Genet. 13, 233-237.
24. Neilson, K. M. and Friesel, R. E. (1995). Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J. Biol. Chem. 270, 26037-26040.
25. Neilson, K. M. and Friesel, R. E. (1996). Ligand-independcnt activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane and kinase domains. J. Biol. Chem. 271, 25049-57.
26. Nomura, S., Wills, A. J., Edwards, D. K., Heath, J. K. and Hogan, B. (1988). Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106, 441-450.
27. Opperman, L. A., Sweeney, T. M., Redmun, J., Persing, J. A. and Ogle, R. C. (1993). Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures. Dev. Dynam. 198, 312-322.
28. Ornitz, D. M., Xu, J., Colvin, J. S., McEwan, D. G., MacArthur, C. A., Coulier, F., Gao, G. and Goldfarh, M. (1996). Receptor specificity of the fibroblast growth factor family. J. Biol. Chem. 271, 15292-15297.
29. Orr-Urtreger, A., Givol, D., Yayon, A., Yarden, Y. and Lonai, P. (1991). Developmental expression of two murine fibroblast growth factor receptors. flg and bek. Development 113, 1419-1434.
30. Orr-Urtreger, A., Bedford, M. T., Burakova, T., Arman, E., Zimmer, Y., Yayon, A., Givol, D. and Lonai, P. (1993). Developmental localisation of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). Dev. Biol. 158, 475-486.
31. Peters, K. G., Werner, G., Chen, G. and Williams, L. T. (1992). Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114, 233-243.
32. Pryzlepa, K. A., Paznekas, W., Zhang, M., Golabi, M., Bias, W., Bamshad, M. J., Carey, J. C., Hall, B. D., Stevenson, R., Orlow, S., Cohen, M. M. Jr. and Jabs, E. W. (1996). Fibroblast growth factor receptor 2 mutations in Beare-Stevenson cutis gyrata syndrome. Nature Genet. 13, 492-494.
33. Raz, V., Kelman, Z., Avivi, A., Neufleld, G., Givol, D. and Yarden, Y. (1991). PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. Oncogene 6, 753-760.
34. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., LeMerrer, M. and Munnich, A. (1994). Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371, 252-254.
35. Shiang, R., Thompson, K. M., Zhou, Y. Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T. and Wasmuth, J. J. (1994). Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism. Cell 78, 335-342.
36. Shimamura, K., Hartigan, D. J., Martinez, S., Puelles, L. and Kubenstein, J. L. R. (1995). Longitudinal organisation of the anterior neural plate and neural tube. Development 121, 3923-3933.
37. Smallwood, P. M., Munoz-Sanjuan, I., Tang, P., Macke, J. P., Hendry, S. H. C., Gilbert, D. J., Copeland, N. G., Jenkins, N. A. and Nathans, J. (1996). Hibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc. Natl. Acad. Sci. USA 93, 9850-9857.
38. Su, W-C. S., Kitagawa, M., Xue, N., Xie, H., Garofalo, S., Cho, J., Deng, C., Horton, W. A. and Fu, X-V. (1997). Activation of Stat 1 by mutant fibroblast growth factor receptor activity in thanatophoric dysplusia type II dwarfism. Nature 386, 288-292.
39. Tavormina, P. L., Rimoin, D. L., Conn, D. H., Zhu, Y-Z., Shiang, R. and Wasmuth, J. J. (1995). Another mutation that results in the substitution of an unpaired cysteinc residue in the extracellular domain of FGFR3 J in thanatophoric dysplasiatype 1. Hum. Mol. Genet. 4, 2175-2177.
40. Webster, M. K. and Donoghue, D. J. (1996). Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520-527.
41. Webster, M. K. and Donoghue, D. J. (1997). FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 13, 178-182.
42. Wilkie, A. O. M., Morriss-Kay, G. M., Jones, K. Y. and Heath, J. K. (1995) Functions of fibroblast growth factors and their receptors. Curr. Biol. 5, 500-507.
43. Wilkie, A. O. M. and Wall, S. A. (1996). Craniosynostosis: novel insights into pathogenesis and treatment. Curr. Opin. Neurobiol. 9, 146-152.
44. Wilkiiuon, D. G. (1992). Whole mount in situ hybridization of vertebrate embryos. In In Situ Hybridization: A Practical Approach (ed. D. G. Wilkinson). pp75-83. IRL Press at Oxford University Press, Oxford.
45. Wood, H. B., Ward, S. J. and Murriss-Kay, G. M. (1996). Effects of all-transretinoic acid on skeletal pattern. 5' HOxD gene expression, and RAR 2/ 4 promoter activity in embryonic mouse limbs. Dev. Genet. 18, 74-84.
46. Yamauuchi, T. P. (1994). fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes. Dev. 8, 3032-3044.
47. Yamasaki, M., Mlyake, A., Tagashira, S. and Itoh, N. (1996). Structure and expression of the rat mRNA encoding a novel member of the fibroblast growth factor family. J. Biol. Chem. 271, 15918-15921.
48. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. and Ornitz, D. M. (1991). Cell surface, heparin-like molecules are required for binding of basic tibroblast growth factor to its high affinity receptor. Cell 64, 841-848.
49. Yayon, A., Zimmer,Y., Guo-Hong, S., Avivi, A., Yarden, Y. and Givol, D. (1992). A confined variable region confers ligand binding specificity on fibroblast growth factor receptors: Implications for the origin of the immunoglobin fold. EMBO J. 11, 1885-1890.